Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000509344 | SCV000334115 | uncertain significance | not provided | 2015-08-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000509344 | SCV000617025 | uncertain significance | not provided | 2016-11-17 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the SCN2A gene. The R1918C variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R1918C variant was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in an external variant database. The R1918C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution alters a conserved residue predicted to be within the C-terminal cytoplasmic domain, and in silico analysis predicts this variant is probably damaging to the protein structure/function. However, missense variants in nearby residues have not been reported in the Human Gene Mutation Database in association with SCN2A-related disorders (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Ambry Genetics | RCV002317801 | SCV000849644 | likely benign | Inborn genetic diseases | 2019-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000509344 | SCV001152497 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SCN2A: BS1 |
Invitae | RCV001034485 | SCV001197842 | likely benign | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV003224250 | SCV003920428 | uncertain significance | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11; Episodic ataxia, type 9 | 2021-03-30 | criteria provided, single submitter | clinical testing | SCN2A NM_021007.2 exon 27 p.Arg1918Cys (c.5752C>T): This variant has not been reported in the literature but is present in 20/125986 European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs139899756). This variant is present in ClinVar (Variation ID:282579). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003985312 | SCV004727357 | likely benign | SCN2A-related disorder | 2020-09-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome |
RCV000509344 | SCV000607254 | not provided | not provided | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Genome |
RCV001265283 | SCV001443400 | uncertain significance | Complex neurodevelopmental disorder | 2018-02-16 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-02-16 and interpreted as Variant of Uncertain significance. Variant was initially reported on 2016-11-23 by GTR ID of laboratory name 26957. The reporting laboratory might also submit to ClinVar. |